Wayne Remell Walker Petros Pharmaceuticals, Inc. (PTPI) insider trading activity

PTPI Quotes by TradingView

Wayne Remell Walker is Director of Petros Pharmaceuticals, Inc.. Currently has a direct ownership of 8,314 shares of PTPI, which is worth approximately $2,577. The most recent transaction as insider was on Apr 26, 2023, when has been sold 6,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.31K
0% 3M change
0% 12M change
Total Value Held $2,577

WAYNE REMELL WALKER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 26 2023
BUY
Exercise of conversion of derivative security
-
6,050 Added 42.12%
8,314 Common Stock
Jan 20 2023
BUY
Exercise of conversion of derivative security
-
2,264 Added 50.0%
2,264 Common Stock

Also insider at

POWW
AMMO, INC. Industrials
Director
WRAP
WRAP TECHNOLOGIES, INC. Technology
PMCB
PharmaCyte Biotech, Inc. Healthcare
Director
AYRO
AYRO, Inc. Consumer Cyclical
Director
WRW

Wayne Remell Walker

Director
Round Rock, TX

Track Institutional and Insider Activities on PTPI

Follow Petros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTPI shares.

Notify only if

Insider Trading

Get notified when an Petros Pharmaceuticals, Inc. insider buys or sells PTPI shares.

Notify only if

News

Receive news related to Petros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTPI